Zentalis Pharmaceuticals, Inc.
$336.07M- Market cap
- $287.40M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.98x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.26x
$4.01Latest market snapshot
Implied fair value · at NWL's multiple
$0.3491.5% below market
0.94 ZNTL revenue / share×0.36x NWL P/S=$0.34
Market $4.01Implied $0.34
NWL · current priceP/S 0.36x
$6.13Latest market snapshot
Implied fair value · at ZNTL's multiple
$72.101,076.2% above market
16.91 NWL revenue / share×4.26x ZNTL P/S=$72.10
Market $6.13Implied $72.10